Ben-Chetrit E, Gattorno M, Gul A, Kastner DL, Lachmann HJ, Touitou I, et al. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a delphi study. Ann Rheum Dis. 2018;77(11):1558–65.
Article CAS PubMed Google Scholar
Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.
Chan AY, Torgerson TR. Primary immune regulatory disorders: a growing universe of immune dysregulation. Curr Opin Allergy Clin Immunol. 2020;20(6):582–90.
Article PubMed PubMed Central Google Scholar
Schnappauf O, Aksentijevich I. Current and future advances in genetic testing in systemic autoinflammatory diseases. Rheumatology (Oxford). 2019;58(Suppl 6):vi44–vi55.
Article CAS PubMed Google Scholar
Başaran Ö, Bilginer Y, Özen S. Rare autoinflammatory diseases. Turk Arch Pediatr. 2022;57(1):18–25.
Article PubMed PubMed Central Google Scholar
Boursier G, Hentgen V, Sarrabay G, Koné-Paut I, Touitou I. The changing concepts regarding the mediterranean fever gene: toward a spectrum of pyrin-associated autoinflammatory diseases with variable heredity. J Pediatr. 2019;209:12–6.e1.
The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807.
de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol. 2015;33:823–74.
Article PubMed PubMed Central Google Scholar
Schutt C, Siegel DM. Autoinflammatory diseases/periodic fevers. Pediatr Rev. 2023;44(9):481–90.
Terreri MT, Bernardo WM, Len CA, da Silva CA, de Magalhães CM, Sacchetti SB, et al. Guidelines for the management and treatment of periodic fever syndromes familial Mediterranean fever. Rev Bras Reumatol Engl Ed. 2016;56(1):37–43.
Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever. N Engl J Med. 1986;314(16):1001–05.
Article CAS PubMed Google Scholar
Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, et al. Rilonacept for colchicine-resistant or -intolerant familial mediterranean fever: a randomized trial. Ann Intern Med. 2012;157(8):533–41.
Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R, et al. An update on familial mediterranean fever. Int J Mol Sci. 2023;24(11).
Özen S, Sag E, Ben-Chetrit E, Gattorno M, Gül A, Hashkes PJ, et al. Defining colchicine resistance/intolerance in patients with familial mediterranean fever: a modified-Delphi consensus approach. Rheumatology (Oxford). 2021;60(8):3799–808.
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20(3):319–25.
Article CAS PubMed Google Scholar
Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med. 2014;65:223–44.
Article CAS PubMed PubMed Central Google Scholar
Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2023;75(3):333–48.
Geck L, Tascilar K, Simon D, Kleyer A, Schett G, Rech J. Anti-Interleukin-1 therapy does not affect the response to SARS-CoV-2 vaccination and infection in patients with systemic autoinflammatory diseases. J Clin Med. 2023;12(24).
Sánchez-Manubens J, Iglesias E, Anton J. Canakinumab for the treatment of hyperimmunoglobulin D syndrome. Expert Rev Clin Immunol. 2019;15(3):215–20.
Berner J, van de Wetering C, Jimenez Heredia R, Rashkova C, Ferdinandusse S, Koster J, et al. Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases. J Allergy Clin Immunol. 2023;152(4):1025–31.e2.
Article CAS PubMed PubMed Central Google Scholar
Georgin-Lavialle S, Ducharme-Benard S, Sarrabay G, Savey L, Grateau G, Hentgen V. Systemic autoinflammatory diseases: clinical state of the art. Best Pract Res Clin Rheumatol. 2020;34(4):101529.
Aksentijevich I, Schnappauf O. Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases. Nat Rev Rheumatol. 2021;17(7):405–25.
Article CAS PubMed Google Scholar
Cugno M, Borghi A, Marzano AV. PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment. Am J Clin Dermatol. 2017;18(4):555–62.
Rivera-Sepulveda A, Colón-Fontánez F, López M, Puig-Ramos G. Deficiency of interleukin-1 receptor antagonist: new genetic autoinflammatory disease as a diagnostic challenge for pediatricians. J Pediatr Genet. 2023;12(3):227–32.
Article CAS PubMed Google Scholar
Garg M, de Jesus AA, Chapelle D, Dancey P, Herzog R, Rivas-Chacon R, et al. Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist. JCI Insight. 2017;2(16).
Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002;81(5):349–68.
Article CAS PubMed Google Scholar
Cudrici C, Deuitch N, Aksentijevich I. Revisiting TNF receptor-associated periodic syndrome (TRAPS): current perspectives. Int J Mol Sci. 2020;21(9).
Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron K, et al. The 2021 EULAR/American college of rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Arthritis Rheumatol. 2022;74(7):1102–21.
Article CAS PubMed PubMed Central Google Scholar
Yu MP, Xu XS, Zhou Q, Deuitch N, Lu MP. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment. World J Pediatr. 2020;16(6):575–84.
Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48(1):67–73.
Article CAS PubMed Google Scholar
Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, et al. Behçet disease (BD) and BD-like clinical phenotypes: NF-κB pathway in mucosal ulcerating diseases. Scand J Immunol. 2020;92(5):e12973.
Elhani I, Riller Q, Boursier G, Hentgen V, Rieux-Laucat F, Georgin-Lavialle S. A20 haploinsufficiency: a systematic review of 177 cases. J Invest Dermatol. 2024;144(6):1282–94.e8.
Article CAS PubMed Google Scholar
Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399.
Article PubMed PubMed Central Google Scholar
Badran YR, Dedeoglu F, Leyva Castillo JM, Bainter W, Ohsumi TK, Bousvaros A, et al. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J Exp Med. 2017;214(7):1937–47.
Article CAS PubMed PubMed Central Google Scholar
Adeeb F, Dorris ER, Morgan NE, Lawless D, Maqsood A, Ng WL, et al. A novel RELA truncating mutation in a familial Behçet’s disease-like mucocutaneous ulcerative condition. Arthritis Rheumatol. 2021;73(3):490–97.
Article CAS PubMed Google Scholar
Lecerf K, Koboldt DC, Kuehn HS, Jayaraman V, Lee K, Mihalic Mosher T, et al. Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant. Rheumatology (Oxf
Comments (0)